Furthermore, the absence of PDLIM2 significantly augments the malignant behavior of NSCLC cells, and reduced expression levels are associated with poor patient survival in lung cancer (Baker et al., 2011). Here, PDLIM2 is linked to non-small cell lung carcinoma.